Elaf Zuhair Mansoor (1), Lamis Aziz Hameed (2), Hayat Yahya Shubbar (3)
Abstract. The most popular and economical screening technique for identifying cervical cancer is the Pap test, which has also proved successful in lowering the incidence and related death rates in women. Aims this research to identify the Relationship between Females’ Demographic Data and Pap Smear Test at Basrah City. A cross-sectional research design. The study population consisted of all women who visited the screening center between January 1, 2013, and December 31, 2015. During this time, 677 women had pap smears and cytological examinations; of these, approximately 60.7% had normal results, 18.8% had LSIL, 4.3% had HSIL, 1% had SCC and adenocarcinoma, 1.2% had ASC-US and AGS-US, and 14% had inflammation. The prevalence of abnormal Pap smear increases with an increase in age, about 27.6% of LSIL and HSIL at age 40 and older. A significant relationship between Pap smear results of women who attended the cervical cancer screening center in Basrah and the following factors: passive smoking, duration of marriage, and parity. No significant relationship was found between Pap smear results and the following factors: age at first marriage and first pregnancy, number of husbands’ wives, socioeconomic status, and education level.
Highlights:
[1] L. Peirson, D. Fitzpatrick-Lewis, D. Ciliska, and R. Warren, “Screening for cervical cancer: a systematic review and meta-analysis,” Syst. Rev., vol. 2, no. 35, pp. 1–14, 2013, doi: 10.1186/2046-4053-2-35.
[2] S. Dobbs and B. Monga, “Premalignant and malignant disease of the cervix,” in Gynaecology by Ten Teachers, A. Ash, Ed., 19th ed., London, UK: Hodder Arnold, 2011, p. 125.
[3] N. Broutet, L. O. Eckert, A. Ullrich, and P. Bloem, “Background, natural history of cancer of the cervix,” in Comprehensive Cervical Cancer Control: A Guide to Essential Practice, 2nd ed., Geneva: World Health Organization, 2014, p. 36.
[4] V. Kumar, A. K. Abbas, and J. C. Aster, “Female genital system and breast: cervix,” in Robbins Basic Pathology, 9th ed., Philadelphia, PA: Saunders, 2013, p. 685.
[5] A. I. Neugut and F. P. Li, “Oncology – cancer epidemiology and prevention,” in ACP Medicine, D. C. Dale and D. D. Federman, Eds., 3rd ed., New York, NY: WebMD, 2007, ch. 12.
[6] M. Markman, “Gynecologic cancers: cervical cancer,” in Goldman’s Cecil Medicine, L. Goldman and A. I. Schafer, Eds., 24th ed., Philadelphia, PA: Saunders, 2012, p. 1317.
[7] M. I. Shafi, “Premalignant and malignant disease of the cervix,” in Dewhurst’s Textbook of Obstetrics & Gynaecology, D. K. Edmonds, Ed., 7th ed., Oxford, UK: Wiley-Blackwell, 2007, p. 614.
[8] J. W. Sellors and R. Sankaranarayanan, Colposcopy and Treatment of Cervical Intraepithelial Neoplasia: A Beginner’s Manual. Lyon: IARC Press, 2003.
[9] L. Ries et al., SEER Cancer Statistics Review, 1975–2005. Bethesda, MD: National Cancer Institute, 2008.
[10] V. Castanon, R. Landy, A. W. W. Lim, and P. Sasieni, “Characteristics and screening history of women diagnosed with cervical cancer aged 20–29 years,” Br. J. Cancer, vol. 109, pp. 35–41, 2013, doi: 10.1038/bjc.2013.322.
[11] N. Rushdan, E. Tay, and J. Low, “Management of preinvasive disease of the cervix,” in Gynaecologic Cancer: A Handbook for Students and Practitioners, 2014, p. 171.
[12] L. H. Ellenson and E. C. Pirog, “The female genital tract: cervix, cervical cancer screening and prevention,” in Robbins and Cotran Pathologic Basis of Disease, 9th ed., Philadelphia, PA: Saunders, 2015, p. 1006.
[13] N. S. Manuel, N. A. Ajeel, and A. F. Al-Assady, “Cervical intraepithelial neoplasia among screened women in Basrah,” Iraqi Board Dissertation, 2012.
[14] U. Banik, P. Bhattacharjee, S. U. Ahamad, and Z. Rahman, “Pattern of epithelial cell abnormality in Pap smear: a clinicopathological and demographic correlation,” Cytojournal, vol. 8, p. 8, 2011.
[15] L. Tao, L. Han, and X. Li, “Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing,” BMC Public Health, vol. 14, p. 1185, 2014, doi: 10.1186/1471-2458-14-1185.
[16] J. Green et al., “Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20–44 years: the UK National case-control study of cervical cancer,” Br. J. Cancer, vol. 89, no. 11, pp. 2078–2086, 2003.
[17] A. Matos, J. Moutinho, D. Pinto, and R. Medeiros, “The influence of smoking and other cofactors on the time to onset of cervical cancer in a southern European population,” Eur. J. Cancer Prev., vol. 14, no. 5, pp. 485–491, 2005.
[18] N. Sogukpinar et al., “Assessment of cervical cancer risk in women between 15 and 49 years of age: case of Izmir,” Asian Pac. J. Cancer Prev., vol. 14, no. 3, pp. 2119–2125, 2013, doi: 10.7314/APJCP.2013.14.3.2119.
[19] C. Remschmidt et al., “Risk factors for cervical human papillomavirus infection and high-grade intraepithelial lesion in women aged 20 to 31 years in Germany,” Int. J. Gynecol. Cancer, vol. 23, no. 3, pp. 519–526, 2013, doi: 10.1097/IGC.0b013e318285a4b2.
[20] H. M. Sharaf, N. S. El-Kinawy, N. M. Awad, and M. F. Gomaa, “Molecular detection and genotyping of human papilloma virus in cervical specimens among Egyptian female patients,” Life Sci. J., vol. 9, no. 2, pp. 768–774, 2012.
[21] K. K. Ward, A. B. Berenson, and C. R. Breitkopf, “Passive smoke exposure and abnormal cervical cytology in a predominantly Hispanic population,” Am. J. Obstet. Gynecol., vol. 204, no. 3, pp. 213–216, 2011.
[22] M. Guillaud et al., “Evaluation of HPV infection and smoking status impacts on cell proliferation in epithelial layers of cervical neoplasia,” PLoS One, vol. 9, no. 9, p. e107088, 2014, doi: 10.1371/journal.pone.0107088.